Research analysts at StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS – Get Free Report) in a research note issued to investors on Monday. The firm set a “hold” rating on the stock.
Separately, Benchmark started coverage on shares of Milestone Scientific in a research note on Thursday, October 10th. They set a “speculative buy” rating and a $1.25 price objective for the company.
Check Out Our Latest Analysis on MLSS
Milestone Scientific Stock Performance
Insider Activity
In related news, Director Leonard Osser sold 107,984 shares of Milestone Scientific stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total transaction of $100,425.12. Following the transaction, the director now owns 4,606,882 shares in the company, valued at approximately $4,284,400.26. The trade was a 2.29 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders have sold 251,106 shares of company stock valued at $236,451 in the last three months. Corporate insiders own 24.75% of the company’s stock.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Milestone Scientific stock. Y Intercept Hong Kong Ltd bought a new stake in shares of Milestone Scientific Inc. (NYSE:MLSS – Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The firm bought 52,368 shares of the company’s stock, valued at approximately $48,000. Y Intercept Hong Kong Ltd owned 0.07% of Milestone Scientific as of its most recent filing with the SEC. Hedge funds and other institutional investors own 5.79% of the company’s stock.
Milestone Scientific Company Profile
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Further Reading
- Five stocks we like better than Milestone Scientific
- Basic Materials Stocks Investing
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- The Significance of Brokerage Rankings in Stock Selection
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- How Investors Can Find the Best Cheap Dividend Stocks
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.